These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Sulfasalazine-Induced Crystalluria Causing Severe Acute Kidney Injury. Durando M; Tiu H; Kim JS Am J Kidney Dis; 2017 Dec; 70(6):869-873. PubMed ID: 28669550 [TBL] [Abstract][Full Text] [Related]
3. Nonsteroidal anti-inflammatory drugs as risk factor for renal failure from acute uric acid nephropathy. Albertazzi A; Cappelli P; Di Paolo B Nephron; 1987; 46(1):98. PubMed ID: 3600919 [No Abstract] [Full Text] [Related]
4. Cases from the Osler Medical Service at Johns Hopkins University. Prutkin J; Zaas D Am J Med; 2003 Jun; 114(8):702-5. PubMed ID: 12798463 [No Abstract] [Full Text] [Related]
5. Sulfasalazine-induced nephrotic syndrome in a patient with ulcerative colitis. Molnár T; Farkas K; Nagy F; Iványi B; Wittmann T Inflamm Bowel Dis; 2010 Apr; 16(4):552-3. PubMed ID: 19637363 [No Abstract] [Full Text] [Related]
6. Adverse effects of sulfasalazine and treatment of ulcerative colitis with mesalazine. Nakajima H; Munakata A; Yoshida Y J Gastroenterol; 1995 Nov; 30 Suppl 8():115-7. PubMed ID: 8563870 [TBL] [Abstract][Full Text] [Related]
7. [A case of acute pancreatitis induced by multiple drugs in a patient with ulcerative colitis]. Son CN; Lee HL; Joo YW; Lee OY; Han DS; Yoon BC; Choi HS; Hahm JS Korean J Gastroenterol; 2008 Sep; 52(3):192-5. PubMed ID: 19077517 [TBL] [Abstract][Full Text] [Related]
8. [A case of ulcerative colitis with folate deficient megaloblastic anemia induced by sulfasalazine]. Hoshino J; Sugawara K; Ishikawa S; Hayami Y; Sakurazawa T; Tanaka T; Yamamoto N; Hashimoto M; Yamamoto T; Hoshihara Y Nihon Shokakibyo Gakkai Zasshi; 1999 Jul; 96(7):840-5. PubMed ID: 10434561 [No Abstract] [Full Text] [Related]
9. [Remission for a patient with ulcerative colitis after agranulocytosis by the side effect of salazosulfapyridine]. Nakamura K; Takeshima F; Shiozawa K; Furusu H; Tomonaga M; Isomoto H; Ohmagari K; Mizuta Y; Murase K; Kohno S Nihon Naika Gakkai Zasshi; 2000 Jan; 89(1):139-41. PubMed ID: 10723929 [No Abstract] [Full Text] [Related]
15. Inducing and maintaining remission in ulcerative colitis: role of high-dose, extended-release mesalamine. Kao J; Kwok K; Das KM J Clin Gastroenterol; 2010 Sep; 44(8):531-5. PubMed ID: 20495466 [TBL] [Abstract][Full Text] [Related]
17. Drug rash with eosinophilia and systemic symptoms secondary to sulfasalazine. Rosenbaum J; Alex G; Roberts H; Orchard D J Paediatr Child Health; 2010 Apr; 46(4):193-6. PubMed ID: 20546480 [TBL] [Abstract][Full Text] [Related]
18. Bilateral obstructing renal stones: an uncommon cause of acute renal failure. Stone JR; Knutson TL; Kang C Am J Emerg Med; 2010 Mar; 28(3):390.e5-6. PubMed ID: 20223414 [TBL] [Abstract][Full Text] [Related]
19. Sulfasalazine inhibits activation of nuclear factor-kappaB in patients with ulcerative colitis. Gan HT; Chen YQ; Ouyang Q J Gastroenterol Hepatol; 2005 Jul; 20(7):1016-24. PubMed ID: 15955209 [TBL] [Abstract][Full Text] [Related]
20. Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases. Tremblay L; Pineton de Chambrun G; De Vroey B; Lavogiez C; Delaporte E; Colombel JF; Cortot A J Crohns Colitis; 2011 Oct; 5(5):457-60. PubMed ID: 21939920 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]